CSIMarket
 
Surgalign Holdings Inc   (SRGA)
Other Ticker:  
 
 
Price: $0.1829 $-0.09 -32.979%
Day's High: $0.238 Week Perf: -19.43 %
Day's Low: $ 0.18 30 Day Perf: -77.45 %
Volume (M): 8,717 52 Wk High: $ 1.83
Volume (M$): $ 1,594 52 Wk Avg: $1.06
Open: $0.24 52 Wk Low: $0.17



 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 13
 Employees -
 Revenues (TTM) (Millions $) 78
 Net Income (TTM) (Millions $) -50
 Cash Flow (TTM) (Millions $) -22
 Capital Exp. (TTM) (Millions $) 10

Surgalign Holdings Inc
Surgalign Holdings Inc. is a leading global surgical and medical technology company that focuses on improving patient outcomes through innovative spine and orthopedic solutions. The company designs, develops, manufactures, and markets high-quality implants and instruments for various surgical procedures. With a wide range of products and offerings, Surgalign aims to address the needs of surgeons and healthcare providers in the ever-evolving healthcare industry. The company's goal is to advance the field of spine and orthopedic medicine through cutting-edge research, development, and collaboration with surgeons and healthcare professionals.


   Company Address: 520 Lake Cook Road Deerfield 60015 IL
   Company Phone Number: 303-4651   Stock Exchange / Ticker: NASDAQ SRGA
   SRGA is expected to report next financial results on March 29, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Surgalign Holdings Inc

Surgalign Holdings Inc Faces Steep Deficit Amidst Weak Sales and Struggles to Compete with Peers in Healthcare Sector

Surgalign Holdings Inc (SRGA) has been experiencing a rough ride lately, with a cumulative net loss of -$50 million during the 12 months ending in the first quarter of 2023. This negative figure has resulted in a negative return on assets (ROA) of -60.88%. These numbers are concerning for investors and suggest that SRGA is struggling to find its footing in the healthcare sector.
To make matters worse, there are 477 other healthcare companies that have a higher return on assets within the same sector. This puts SRGA at a significant disadvantage and indicates that it is far behind its competitors in terms of profitability and financial stability.






 

Surgalign Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com